First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
Clinical trial NCT01419249 · COMPLETED
Trial details
- NCT number
- NCT01419249
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.